Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Neurocognitive and familial moderators of psychiatric risk in velocardiofacial (22q11.2 deletion) syndrome: a longitudinal study.
[22q11.2 deletion syndrome]
Although
risk
for
psychosis
in
velocardiofacial
(
22
q
11
.
2
deletion
)
syndrome
(
VCFS
)
is
well
established
,
the
cognitive
and
familial
factors
that
moderate
that
risk
are
poorly
understood
.
A
total
of
75
youth
with
VCFS
were
assessed
at
three
time
points
,
at
3
-
year
intervals
.
Time
1
(
T
1
)
psychiatric
risk
was
assessed
with
the
Behavior
Assessment
System
for
Children
(
BASC
)
.
Data
reduction
of
BASC
scores
yielded
avoidance-
anxiety
and
dysregulation
factors
.
Time
2
(
T
2
)
neuropsychological
and
family
function
and
time
3
(
T
3
)
prodromal
/
overt
psychosis
were
assessed
.
Poisson
regression
models
tested
associations
between
T
3
positive
prodromal
symptoms
/
overt
psychosis
and
T
1
psychiatric
risk
,
T
2
cognitive
and
familial
factors
,
and
their
interactions
.
T
1
avoidance-
anxiety
ratings
predicted
T
3
prodromal
/
overt
psychosis
.
T
2
verbal
learning
scores
moderated
this
association
,
such
that
individuals
with
low
avoidance-
anxiety
scores
and
stronger
verbal
learning
skills
were
the
least
likely
to
demonstrate
prodromal
/
overt
psychosis
at
T
3
.
Low
scores
on
a
T
2
visual
vigilance
task
also
predicted
T
3
prodromal
/
overt
psychosis
,
independently
of
the
effect
of
T
1
avoidance-
anxiety
scores
.
T
1
dysregulation
scores
did
not
predict
T
3
prodromal
/
overt
psychosis
in
a
linear
manner
.
Instead
,
the
association
between
dysregulation
and
prodromal
/
overt
psychosis
was
amplified
by
T
2
levels
of
family
organization
,
such
that
individuals
with
low
dysregulation
scores
and
low
family
organization
scores
were
the
most
likely
to
exhibit
T
3
prodromal
/
overt
psychosis
.
Significant
moderators
of
psychiatric
risk
in
VCFS
include
verbal
learning
skills
as
well
as
levels
of
family
organization
,
carrying
implications
for
early
identification
and
preventative
treatment
of
youth
with
VCFS
at
highest
risk
for
psychosis
.
Diseases
Validation
Diseases presenting
"early identification"
symptom
22q11.2 deletion syndrome
allergic bronchopulmonary aspergillosis
congenital toxoplasmosis
cutaneous mastocytosis
esophageal carcinoma
kabuki syndrome
krabbe disease
phenylketonuria
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom